Therapeutic Drug Monitoring Market

Therapeutic Drug Monitoring Market


Therapeutic drug monitoring is a branch of clinical chemistry and clinical pharmacology which aims at maintaining the drug concentration levels in the body fluids within the particular therapeutic range. The purpose of therapeutic drug monitoring is refining patient care by individually adjusting the drug dosage for better outcomes.

Some of the situations where measurement of drug dosage concentration is useful include, non-response at therapeutic dose, suboptimal tolerability, pharmacokinetic drug-drug interaction and drug adherence. TDM is regarded as a module of personalized medicine that interacts with various other disciplines such as pharmacogenomics and pharmacokinetics. Most commonly monitored drugs are digoxin, valproate and carbamazepine.

The global therapeutic drug monitoring market showed significant growth over the last few years and is projected to grow at a robust CAGR during the forecast period.

Therapeutic Drug MonitoringMarket: Drivers and Restraints

Therapeutic drug monitoring is driven by various key factors which include, ageing population with better health care services, increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring markets, rise in drug profiling.

Ongoing problems with reimbursement, retrenchment in the hospital fields and a weak global economy. Fluctuating exchange rates further weakens the global market.

Therapeutic Drug MonitoringMarket: Segmentation

Global therapeutic drug monitoring market is segmented on the basis of product type as following:

Antibiotics
Anticonvulsants
Antiarrhythmic
Antineoplastic
Bronchodilators
Immunosuppressive
HIV/AIDS drugs
Therapeutic drug monitoring market is further segmented on the basis of technology as:

Spectrometry
Chromatography
Electrophoresis
Proteomic technology
Therapeutic Drug MonitoringMarket: Overview         

With the advancement of technology and increase incidence in disease population, therapeutic drug monitoring, is gaining wide acceptance as a method of choice among patients. This market is expected to grow at a healthy CAGR in the forecast period (2015-2025).

In the upcoming years, the TDM market will undergo significant transformation. These alterations will be done by convergence of new and more stringent regulations improvements in diagnostic technologies, automation and system engineering.

Therapeutic Drug MonitoringMarket: Region-wise Outlook  

Depending on geographic regions, therapeutic drug monitoring market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

In terms of geography, North America dominates the therapeutic drug monitoring market, followed by Europe. During the earlier stages of this market development growth rates were higher, while the value of the market was relatively low. As the market value started to rise the annual growth rate declined slightly, but is expected to increase again as the market develops and the advantages of therapeutic drug monitoring is appreciated in the established markets and as the techniques and products appear in the emerging market.

Therapeutic Drug MonitoringMarket: Key Players    

Coulter, BioChem Pharmaceuticals, BioRad, OraSure Technologies,and Roche Diagnostics. The market is currently led by Some of the key players in compression therapy market are,Abbott Laboratories, Bayer AG, Beckman Roche diagnostics followed by Abbott Laboratories.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint.
NOTE - All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.


1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast, 2022-2032
4.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis, 2017-2021
4.2. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Projections, 2022-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Analyte
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Analyte, 2017-2021
5.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Analyte, 2022-2032
5.3.1. Analgesics
5.3.2. Antifungal
5.3.3. Antibiotics
5.3.4. Antiepileptic
5.3.5. Antineoplastic & Cancer Chemotherapy
5.3.6. Antiretroviral/Anti-HIV Drugs
5.3.7. Analeptics & Bronchodilators
5.3.8. Anti-arrhythmic Drugs
5.3.9. Antihypertensive
5.3.10. Immunosuppressive Agents
5.3.11. Psychoactive Agents
5.3.12. Addiction Therapeutics
5.3.13. Antihypertensive
5.3.14. Hormones
5.3.15. Anticoagulants
5.3.16. Antilipidemic
5.3.17. Alzheimer’s Therapeutics
5.4. Y-o-Y Growth Trend Analysis By Analyte, 2017-2021
5.5. Absolute $ Opportunity Analysis By Analyte, 2022-2032
-dive segmentation will be available in the sample on request
6. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Technique
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Technique, 2017-2021
6.3. Current and Future Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Technique, 2022-2032
6.3.1. Immunoassay
6.3.2. Mass Spectrometry
6.3.3. Other Techniques
6.4. Y-o-Y Growth Trend Analysis By Technique, 2017-2021
6.5. Absolute $ Opportunity Analysis By Technique, 2022-2032
-dive segmentation will be available in the sample on request
7. Global Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis By Region, 2017-2021
7.3. Current Market Size Value (US$ Mn) & Volume (No. of Tests) Analysis and Forecast By Region, 2022-2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia & Pacific
7.3.6. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
8.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
8.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Analyte
8.2.3. By Technique
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Analyte
8.3.3. By Technique
8.4. Key Takeaways
9. Latin America Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
9.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
9.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Analyte
9.2.3. By Technique
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Analyte
9.3.3. By Technique
9.4. Key Takeaways
10. Europe Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
10.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
10.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Analyte
10.2.3. By Technique
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Analyte
10.3.3. By Technique
10.4. Key Takeaways
11. East Asia Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
11.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
11.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Analyte
11.2.3. By Technique
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Analyte
11.3.3. By Technique
11.4. Key Takeaways
12. South Asia & Pacific Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
12.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
12.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Thailand
12.2.1.3. Indonesia
12.2.1.4. Malaysia
12.2.1.5. Singapore
12.2.1.6. Australia
12.2.1.7. New Zealand
12.2.1.8. Rest of South Asia & Pacific
12.2.2. By Analyte
12.2.3. By Technique
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Analyte
12.3.3. By Technique
12.4. Key Takeaways
13. MEA Therapeutic Drug Monitoring Market Analysis 2017-2021 and Forecast 2022-2032, By Country
13.1. Historical Market Size Value (US$ Mn) & Volume (No. of Tests) Trend Analysis By Market Taxonomy, 2017-2021
13.2. Market Size Value (US$ Mn) & Volume (No. of Tests) Forecast By Market Taxonomy, 2022-2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Analyte
13.2.3. By Technique
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Analyte
13.3.3. By Technique
13.4. Key Takeaways
14. Key Countries Therapeutic Drug Monitoring Market Analysis
14.1. U.S.
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Analyte
14.1.2.2. By Technique
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Analyte
14.2.2.2. By Technique
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Analyte
14.3.2.2. By Technique
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Analyte
14.4.2.2. By Technique
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Analyte
14.5.2.2. By Technique
14.6. U.K.
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Analyte
14.6.2.2. By Technique
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Analyte
14.7.2.2. By Technique
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Analyte
14.8.2.2. By Technique
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Analyte
14.9.2.2. By Technique
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Analyte
14.10.2.2. By Technique
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Analyte
14.11.2.2. By Technique
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Analyte
14.12.2.2. By Technique
14.13. India
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Analyte
14.13.2.2. By Technique
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Analyte
14.14.2.2. By Technique
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Analyte
14.15.2.2. By Technique
14.16. Malaysia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Analyte
14.16.2.2. By Technique
14.17. Singapore
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Analyte
14.17.2.2. By Technique
14.18. Australia
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Analyte
14.18.2.2. By Technique
14.19. New Zealand
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Analyte
14.19.2.2. By Technique
14.20. GCC Countries
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Analyte
14.20.2.2. By Technique
14.21. South Africa
14.21.1. Pricing Analysis
14.21.2. Market Share Analysis, 2021
14.21.2.1. By Analyte
14.21.2.2. By Technique
14.22. Israel
14.22.1. Pricing Analysis
14.22.2. Market Share Analysis, 2021
14.22.2.1. By Analyte
14.22.2.2. By Technique
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Analyte
15.3.3. By Technique
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Thermo Fisher Scientific Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Abbott
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Roche Diagnostics
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Bio-Rad Laboratories
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Sigma-Aldrich
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Beckman Coulter, Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. Randox Laboratories Ltd.
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. SEKISUI MEDICAL CO., LTD.
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Chromsystems Instruments & Chemicals GmbH
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. SJK Global, LLC.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Alpha Laboratories
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings